MedPath

Patient information combined for local therapy outcome assessment in bresast cancer.

Conditions
breast cancer
10006232
carcinoma of the breast
Registration Number
NL-OMON41193
Lead Sponsor
eids Universitair Medisch Centrum
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Not specified
Target Recruitment
100
Inclusion Criteria

Women who have undergone breast conserving surgery for early breast cancer more than one year ago.
Written informed consent obtained.

Exclusion Criteria

Unable to provide written informed consent.
Younger than 18 years.
Benign breast disease.
Women who have had a mastectomy.

Study & Design

Study Type
Observational non invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>The primary objective will be to create a reliable demonstrator (software) by<br /><br>integrating models of surgical techniques and treatment schemes, clinical<br /><br>patient data, multimodal imaging and individualised models of patient anatomy. </p><br>
Secondary Outcome Measures
NameTimeMethod
<p>The secondary objective will be to assess the health related quality of life in<br /><br>the women who are participating in this study.<br /><br>The information obtained from this study will be used in the creation of a<br /><br>demonstrator (personalised digital representation of a patient) by integrating<br /><br>models of surgical techniques and treatment schemes, clinical patient data,<br /><br>multimodal imaging and individualised models of patient anatomy.<br /><br><br /><br>The aim is to create a demonstrator that will be used as an aid to objective<br /><br>surgical planning, via simulation of the cosmetic effects of breast conserving<br /><br>surgery, as a decision support tool to communicate the available options to the<br /><br>patient and to enable standardised evaluation of the procedure.</p><br>
© Copyright 2025. All Rights Reserved by MedPath